Full text

Turn on search term navigation

© 2025 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objectives

Long-acting reversible contraception (LARC) provides continuous pregnancy prevention to women for a period of 3 to 12 years, and it is very safe and effective. The aim of this study was to determine the prevalence, determinants and willingness to use LARC among undergraduate female students attending public and private universities in Ekiti State, Southwest Nigeria

Design

This survey employed a cross-sectional comparative study design.

Setting

Public and private universities in Ekiti State, Southwest Nigeria.

Participants

418 female students in their undergraduate years at public and private universities (208 students in public universities and 210 students in private universities).

Primary and secondary outcomes

A semistructured questionnaire was used to gather data, and analysis was done using IBM SPSS V.25. Prevalence, willingness and determinants of LARC were determined and compared between public and private universities at the level of bivariate analysis using χ2. Multivariate regression analysis was used to determine the predictor of LARC use. The statistical significance level was placed at a p value of <0.05.

Results

The mean age of female undergraduate students was higher in public universities (21.1±2.5 years) than in private universities (19.3±2.1 years). The prevalence of LARC usage among the sexually active respondents was 12.5% for public universities and 12.7% for private universities. Determinants and predictors of LARC uptake among the students in both university settings were age, marital status and good knowledge of LARC. Only about one quarter (24.0% in public universities and 24.8% in private universities) were willing to take up LARC among the students in both settings.

Conclusion

The prevalence and willingness to take up LARC in the public and private universities are still low. Determinants and predictors of LARC uptake include age, marital status and good knowledge of LARC.

Details

Title
Comparative cross-sectional study on the prevalence, determinants and willingness to use long-acting reversible contraception among female students attending public and private universities in Ekiti State, Southwest Nigeria
Author
Taofeek, Adedayo Sanni 1   VIAFID ORCID Logo  ; Kabir, Adekunle Durowade 1 ; Elegbede, Olusegun Elijah 1 ; Adewoye, Kayode Rasaq 1 ; Oluseyi Adedeji Aderinwale 2 ; Tope, Michael Ipinnimo 1   VIAFID ORCID Logo  ; John Olujide Ojo 1 ; Ayo Kamal Alabi 1 ; Agbana, Richard Dele 3 ; Bosan, Joy 4 

 Department of Community Medicine, Afe Babalola University, Ado-Ekiti, Nigeria; Department of Community Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria 
 Department of Obstetrics and Gynaecology, Federal Medical Centre, Abeokuta, Nigeria 
 Department of Community Medicine, Afe Babalola University, Ado-Ekiti, Nigeria 
 Department of Law, Afe Babalola University, Ado-Ekiti, Nigeria 
First page
e087123
Section
Reproductive medicine
Publication year
2025
Publication date
2025
Publisher
BMJ Publishing Group LTD
e-ISSN
20446055
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3152207430
Copyright
© 2025 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.